Injective
Why Injective is up 4.0% today
Analysis
Injective (INJ) rose about 4% over the past 24 hours as ETF-related headlines boosted sentiment. The Block reported that Injective CEO Eric Chen expects US INJ ETFs to arrive sooner than 2027, reinforcing expectations of potential mainstream access.
Contributing Factors (2)
Injective CEO Eric Chen expects US INJ ETFs to launch sooner than 2027
There are currently two ETF applications tied to INJ — the 21Shares Injective ETF and the Canary Staked INJ ETF.
Injective launches Trench Treasury as Canary files SEC ETF – Details
Injective ecosystem saw two major developments; Injective Foundation launched the Trench Treasury while Canary Capital filed with the SEC for Staked INJ ETF.
Move Details
Explanation Confidence
High confidence in the explanation based on source reliability and timing.